Date: July 26, 2026
Other Operational / Legal / Strategic Disclosures
Regulatory Action on Subsidiary:
- Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received a suspension order for a Drug License.
- The affected store is located at Busstand Road, Bijapur, Karnataka.
Details of the Order:
- Issuing Authority: Assistant Director, Drugs Control Administration, Vijayapura Circle, Vijayapura, Karnataka.
- Nature of Action: Suspension of Drug License for a period of two days.
- Date of Receipt: The order was received on July 25, 2026.
- Alleged Violation: The action is under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
- Financial Impact: The company has quantified the potential impact as a revenue loss of ₹0.29 lacs.
Regulatory Context:
- The company also references SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026.
Availability:
- The details of this matter will be available on the company's website (www.medplusindia.com) and on the websites of BSE Limited (www.bseindia.com) and the National Stock Exchange of India Ltd. (www.nseindia.com).
KMP / Board / Auditor Changes
Not Specified
Dividend Declaration or Non-Declaration
Not Specified
Board Meeting Outcomes
Not Specified
Financial Results (Standalone & Consolidated)
Not Specified
Auditor’s Report
Not Specified
Disinvestment / Strategic Actions
Not Specified